Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Steven

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Breast Care (Basel, Switzerland)|June 29, 2018
The Role of Immune Escape and Immune Cell Infiltration in Breast CancerAndré Steven, Barbara Seliger
Oncotarget|March 3, 2016
Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic targetAndré Steven, Barbara Seliger
Cancer Immunology, Immunotherapy : CII|February 7, 2020
"Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, GermanyAndré Steven, Chiara Massa, Barbara Seliger
International Journal of Molecular Sciences|July 29, 2020
The Role of the RNA-Binding Protein Family MEX-3 in TumorigenesisSimon Jasinski-Bergner, André Steven, Barbara Seliger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activityYumeng Mao, Dhifaf Sarhan, André Steven, et al.
Cellular and Molecular Life Sciences : CMLS|April 30, 2020
What turns CREB on? And off? And why does it matter?André Steven, Michael Friedrich, Paul Jank, et al.
Oncoimmunology|April 11, 2018
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cellsKarthikeyan Subbarayan, Sandra Leisz, Claudia Wickenhauser, et al.
Molecular Cancer Research : MCR|May 3, 2015
Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In VivoAndré Steven, Max Heiduk, Christian V Recktenwald, et al.
Oncoimmunology|May 9, 2022
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cellsKarthikeyan Subbarayan, Chiara Massa, Sandra Leisz, et al.
Oncotarget|December 13, 2017
Linking CREB function with altered metabolism in murine fibroblast-based model cell linesAndré Steven, Sandra Leisz, Claudia Wickenhauser, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Breast Care (Basel, Switzerland)|June 29, 2018
The Role of Immune Escape and Immune Cell Infiltration in Breast CancerAndré Steven, Barbara Seliger
Oncotarget|March 3, 2016
Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic targetAndré Steven, Barbara Seliger
Cancer Immunology, Immunotherapy : CII|February 7, 2020
"Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, GermanyAndré Steven, Chiara Massa, Barbara Seliger
International Journal of Molecular Sciences|July 29, 2020
The Role of the RNA-Binding Protein Family MEX-3 in TumorigenesisSimon Jasinski-Bergner, André Steven, Barbara Seliger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activityYumeng Mao, Dhifaf Sarhan, André Steven, et al.
Cellular and Molecular Life Sciences : CMLS|April 30, 2020
What turns CREB on? And off? And why does it matter?André Steven, Michael Friedrich, Paul Jank, et al.
Oncoimmunology|April 11, 2018
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cellsKarthikeyan Subbarayan, Sandra Leisz, Claudia Wickenhauser, et al.
Molecular Cancer Research : MCR|May 3, 2015
Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In VivoAndré Steven, Max Heiduk, Christian V Recktenwald, et al.
Oncoimmunology|May 9, 2022
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cellsKarthikeyan Subbarayan, Chiara Massa, Sandra Leisz, et al.
Oncotarget|December 13, 2017
Linking CREB function with altered metabolism in murine fibroblast-based model cell linesAndré Steven, Sandra Leisz, Claudia Wickenhauser, et al.
Pageof 2